// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
The HALO Trust has cleared 88% of the known minefields in Karabakh and is hopeful that by 2020 Karabakh will be 100% mine free.
the ministry of nature protection continues implementing thorough inspections at Dilijan national park prevent illegal logging and poaching cases.
According to a report published by SCImago database, Armenia is ranked 65th globally among a total of 239 countries and territories.
Cases of abuse of power or official misconduct also decreased in the reporting period, dropping to 136 from 168 a year before.
Partner news